Omission of day +11 methotrexate dose and allogeneic hematopoietic cell transplantation outcomes: results of a systematic review/meta-analysis-Reference-Cited by-同舟云学术

Omission of day +11 methotrexate dose and allogeneic hematopoietic cell transplantation outcomes: results of a systematic review/meta-analysis

Published:2021-10-12 Issue:1 Volume:57 Page:65-71
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Kharfan-Dabaja Mohamed A.^ORCID,Reljic Tea^ORCID,Kumar Arni^ORCID,Yassine Farah^ORCID,Keller Katelyn^ORCID,Fernandez Andre,Murthy Hemant,Ayala Ernesto,Aljurf Mahmoud,Iqbal Madiha^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-021-01496-3.pdf

Reference31 articles.

1. Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M, et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med. 2010;363:2091–101.

2. Kharfan-Dabaja MA, Al Malki MM, Deotare U, Raj RV, El-Jurdi N, Majhail N, et al. Haematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a North American multicentre collaborative study. Br J Haematol. 2017;179:781–9.

3. Hsieh MM, Kang EM, Fitzhugh CD, Link MB, Bolan CD, Kurlander R, et al. Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. N Engl J Med. 2009;361:2309–17.

4. Hamilton BK, Storer BE, Wood WA, Pidala JA, Cutler CS, Martin PJ, et al. Disability related to chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2020;26:772–7.

5. Storb R, Pepe M, Deeg HJ, Anasetti C, Appelbaum FR, Bensinger W, et al. Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia. Blood. 1992;80:560–1.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical outcomes of patients receiving three versus four doses of methotrexate with concomitant antithymocyte globulin in match unrelated donor allogeneic stem cell transplant: A single‐center experience;eJHaem;2024-04-28

2. Significance of Omitting Day 11 Mini-Dose Methotrexate for GVHD Prophylaxis After Unrelated Bone Marrow Transplantation;Transplantation and Cellular Therapy;2023-02

3. Impact of omitting post-transplant minidose-methotrexate doses in allogeneic hematopoietic cell transplantation;Leukemia & Lymphoma;2022-02-10